In an independent study by Stanford and Harvard, physicians chose OpenEvidence over other AI chatbots, including ChatGPT, Claude, and Gemini, as their preferred AI resource for clinical consultations.

US · 2026-07-20

1. Step 1 · The triggerStanford/Harvard study shows physicians prefer OpenEvidence over ChatGPT, Claude, Gemini combined.
2. Step 2 · Knock-onOpenEvidence gains credibility and adoption momentum in clinical settings, driving revenue growth.
3. Step 3 · Reaches youCompeting AI chatbots face pressure to develop specialized medical modules or lose market share in healthcare.

The trigger is reported by the source below. The steps that follow are Branch²’s traced reasoning — how the shock could reach a business like yours, not a prediction.

Source: PR Newswire

This is automated analysis for information only. It is not investment advice, not a recommendation, and not a solicitation to buy or sell any security. Branch² is not authorised or regulated. Do your own research.